ADMA Biologics Inc (NASDAQ:ADMA)

5.29
Delayed Data
As of May 25
 +0.01 / +0.19%
Today’s Change
2.01
Today|||52-Week Range
5.70
+64.80%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-16.8M-18.0M-19.5M-43.8M
 
 
 
 
 
Depreciation247.9K469.8K469.6K2.7M
 
 
 
 
 
Total Other Cash Flow1.7M2.8M1.8M4.1M
 
 
 
 
 
Funds From Operations-14.9M-14.7M-17.3M-37.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-177.9K671.1K1.0M282.2K
 
 
 
 
 
Net Cash Flow - Operating Activities-14.7M-15.4M-18.3M-37.3M
 
 
 
 
 
 
InvestingIncrease In Investments-1.7M-1.7M-15.7M0.00
 
 
 
 
Decrease In Investments0.000.0016.7M5.4M
 
 
 
Capital Expenditures-2.3M-26.1K-73.4K-2.7M
 
 
 
 
 
Fixed Asset Disposal------12.5M
 
 
Net Cash Flow Investing-4.0M-1.7M904.6K15.2M
 
 
 
 
 
 
FinancingShort Term Borrowings------0.00--
Long Term Borrowings9.8M15.8M4.0M43.3M
 
 
 
 
 
Long Term Debt Reduction-12.7K-15.5M-15.1K-20.0M
 
 
 
 
 
Net Proceeds Stock Sale-12.0K10.3M12.9M39.2M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends------0.00--
Cash Dividends Paid - Total------0.00--
Other Sources - Financing0.00--0.00----
Other Uses - Financing0.00132.5K0.001.8M
 
 
 
Net Cash Flow - Financing9.8M10.4M16.8M60.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-9.0M-6.8M-526.1K38.7M